Cellulose beads bound to cellulose binding domain-fused recombinant proteins; an adjuvant system for parenteral vaccination of fish

Vaccine

Volumn 21, Issue 23, 2003, Pages 3200-3207

  Maurice, Sarah ^a   Dekel, Mara ^a   Shoseyov, Oded ^a   Gertler, Arieh ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adjuvant; Cellulose binding domain (CBD); Recombinant A protein

Indexed keywords

BACTERIN; CELLULOSE; OUTER MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

AEROMONAS SALMONICIDA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CLOSTRIDIUM; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLDFISH; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; IMMUNOPOTENTIATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN ISOLATION; VACCINIA;

EID: 0038120859     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00231-7     Document Type: Article

References (35)

1. Anderson D.P., Jeney G. Immunostimulants added to injected Aeromonas salmonicida bacterin enhance the defense mechanisms and protection in rainbow trout (Oncorhynchus mykiss). Vet. Immunol. Immunopathol. 34(3-4):1992;379-389.
2. Anderson D.P. Adjuvants and immunostimulants for enhancing vaccine potency in fish. Dev. Biol. Stand. 90:1997;257-265.
3. Ronsholdt B., Mclean E. The effect of vaccination and vaccine components upon short-term growth and feed conversion efficiency in rainbow trout. Aquaculture. 174(3-4):1999;213-221.
4. Midtlyng P.J. Vaccinated fish welfare: protection versus side-effects. Dev. Biol. Stand. 90:1997;371-379.
5. Ellis A.E. Immunization with bacterial antigens: furunculosis. Dev. Biol. Stand. 90:1997;107-116.
6. Midtlyng P.J., Reitan L.J., Speilberg L. Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon (Salmo salar L.) against furunculosis. Fish Shellfish Immunol. 6:1996;335-350.
7. Lillenhaug A., Lunder T. Field testing of adjuvanted furunculosis vaccines in Atlantic salmon Salmo salar L. J. Fish Dis. 6:1992;155-174.
8. Partidos C.D., Stanley C.M., Steward M.W. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins. J. Gen. Virol. 72:1991;1293-1299.
9. Borras-Cuesta F., Petit-Camurdan A., Fedon Y. Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells. Eur. J. Immunol. 17:1987;1213-1215.
10. Christie K.E. Immunization with viral antigens: infectious pancreatic necrosis. Dev. Biol. Stand. 90:1997;191-199.
11. Grudding R.A., Lillenhaug A., Ebensen D. Recent developments in fish vaccinology. Vet. Immunol. Immunopath. 72:1999;203-212.
12. Lorenzen N., LaPatra S. Immunity to rhabdoviruses in rainbow trout: the antibody response. Fish Shellfish Immunol. 9:1999;345-360.
13. Leong JC, Anderson E, Bootland LM, Chiou P-W, Johnson M, Kim C. Fish vaccine antigens produced or delivered by recombinant DNA technologies. In: Midtlyng PJ, Brown F, editors. Fish Vaccinology. Basel: Karger. Dev Biol Stand 1997;90:267-77.
14. Mowat M., Donachie A.M., Jagewall S., Schon K., Lowenadler B., Dalsgaard K.et al. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen. Immunol. Invest. 15 (167/6):2001;3398-3405.
15. Wiesmuller K.H., Fleckenstein B., Jung G. Peptide vaccines and peptide libraries. Biol. Chem. 382(4):2001;571-579.
16. Reddin K.M., Easterbrook T.J., Eley S.M., Russel P., Mobsby V.A., Jones D.H.et al. Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis. Vaccine. 16(8):1998;761-767.
17. Brayden D.J., Templeton L., McClean S., Barbour R., Huang J., Nguyen M.et al. Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered beta-amyloid in mice. Vaccine. 19(30):2001;4185-4193.
18. Moynihan J.S., Jones D.H., Farrar G.H., Howard C.R. A novel microencapsulated peptide vaccine against hepatitis B. Vaccine. 19:2001;3292-3300.
19. Higaki M., Asechi Y., Takase T., Igarashi R., Nagafara S., Sano A.et al. Collagen minipellet as a controlled release delivery system for tetanus and diptheria toxoid. Vaccine. 19:2001;3091-3096.
20. Shoseyov O., Doi R.H. Essential 170 kDa subunit for degradation of crystalline cellulose by Clostridium cellulovorans. Proc. Natl. Acad. Sci. U.S.A. 87(6):1990;2192-2195.
21. Levy I., Shoseyov O. Cellulose-binding domains. Biotechnological approaches. Biotech. Adv. 20:2002;191-213.
22. Maurice S., Hadge D., Dekel M., Friedman A., Gertler A., Shoseyov O. A-protein from achromogenic atypical Aeromonas salmonicida: molecular cloning, expression, purification, and characterization. Protein Exp. Purif. 16(3):1999;396-404.
23. Shipgel E., Goldlust A., Efroni G., Avrah A., Eshel A., Dekel M.et al. Immobilization of recombinant heparinase I fused to cellulose-binding domain. Biotech. Bioeng. 65(1):1999;17-23.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature. 227:1970;680-685.
25. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology. 24:1992;145-149.
26. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
27. Cruickshank R, Duguid J, Swain R. Counting bacteria. In: Medical microbiology. Edinburgh and London: E & S Livingston Ltd.; 1965. p. 870.
28. Tomme P., Boraston A., McLean B., Kormos J., Creagh L., Sturch K.et al. Characterization and affinity application of cellulose binding domains. J. Chromatogr. 715:1998;283-296.
29. Goldstein M.A., Takagi M., Hashida S., Shoseyov O., Doi R.H., Segal I.H. Characterization of the cellulose-binding domain of the Clostridium cellulorvorans cellulose-binding protein-A. J. Bacteriol. 176:1993;5762-5768.
30. Chu S., Cavaignac S., Feutrier J., Phipps B.M., Kostrzynska M., Kay W.W.et al. Structure of the tetragonal surface virulence array protein and gene of Aeromonas salmonicida. J. Biol. Chem. 266(23):1991;15258-15265.
31. Ishiguro E.E., Kay W.W., Ainsworth T., Chamberlain J.B., Austen R.A., Buckley J.T.et al. Loss of virulence during culture of Aeromonas salmonicida at high temperature. J. Bacteriol. 148(1):1981;333-340.
32. Kay W.W., Buckley J.T., Ishiguro E.E., Phipps B.M., Monette J.P., Trust T.J. Purification and disposition of a surface protein associated with virulence of Aeromonas salmonicida. J. Bacteriol. 147(3):1981;1077-1084.
33. Munn C.B., Ishiguro E.E., Kay W.W., Trust T.J. Role of surface components in serum resistance of virulent Aeromonas salmonicida. Infect. Immunol. 36(3):1982;1069-1075.
34. Gudmundsdottir B.K., Magnadottir B. Protection of Atlantic salmon (Salmo salar L.) against an experimental infection of Aeromonas salmonicida ssp achromogenes. Fish Shellfish Immunol. 7:1997;55-69.
35. Gudmundsdottir B.K., Jonsdottir H., Steinthorsdottir V., Magnadottir B., Gudmundsdottir S. Survival and humoral antibody response of Atlantic salmon, Salmo salar L., vaccinated against Aeromonas salmonicida ssp achromogenes. J. Fish Dis. 20:1997;351-360.